Orthopedics
Chinese Army Established the First Chest Pain Rescue Network in China by Using IVT mHealth System
March 26, 2011 5:33 pm | by Bio-Medicine.Org | News | CommentsGUANGZHOU, China, March 27, 2011 /PRNewswire-Asia/ -- Guangzhou General Hospital of Peoples Liberation Army (PLA) made a landmark announcement that the first Chinese regional military and civilian coordinated Chest Pain Rescue Network using IVT mobile health (mHealth) system is now in...
A Genomic Blueprint for Cancer
March 23, 2011 8:32 pm | by Massachusetts Institute of Technology | News | CommentsThe largest cancer genome sequencing project yet highlights molecular pathways at the heart of an aggressive blood cancer.
CVS/pharmacy Debuts the "To Your Health" Program in Los Angeles Bringing 240 Free Health Screening Events to the Community
March 23, 2011 10:32 am | by Bio-Medicine.Org | News | CommentsLOS ANGELES, March 23, 2011 /- CVS/pharmacy, the nation's leading retail pharmacy, brings its "To Your Health" free health screening program to Los Angeles, Calif. on Saturday, March 26. The program will provide free preventive health screenings for Los Angeles area residents at 240...
Polar Partners with 'Shedding for the Wedding' Trainer and NGRâ„¢ President and CEO Jennifer Cohen
March 23, 2011 7:31 am | by Bio-Medicine.Org | News | CommentsLAKE SUCCESS, N.Y., March 23, 2011 /- Polar ( www.polarusa.com ), the leader in heart rate monitoring and fitness assessment technology, today announced a partnership with celebrity fitness trainer and health authority Jennifer Cohen . Polar selected Cohen, president and CEO of...
Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedule
March 22, 2011 5:33 am | by Bio-Medicine.Org | News | CommentsMADISON, Wis., March 22, 2011 /- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's iCell® Cardiomyocytes as a predictive tool for assessing the potential cardiotoxic effects of...
GeNO LLC Initiates Study of Inhaled NITROSYLâ„¢ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients
March 22, 2011 5:32 am | by Bio-Medicine.Org | News | CommentsCOCOA, Fla., March 22, 2011 /- GeNO LLC ( www.genollc.com ), a privately held, advanced development-stage technology company, today announced commencement of the PHiano Study: A Phase 2, Dose-Escalation Trial for the Treatment of Pulmonary Hypertension in patients with Pulmonary...
Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities
March 17, 2011 5:32 am | by Bio-Medicine.Org | News | CommentsSTAMFORD, Conn., March 17, 2011 /- ACC Booth # 2001 -- Further enhancing its cardiovascular reporting capabilities, FUJIFILM Medical Systems U.S.A., Inc. is pleased to announce the availability of its Intelligent Structured Reporting (ISR) technology. An advanced software decision support...
Argon Medical Devices Announces Exclusive License and Distribution Agreement for Optionâ„¢ Retrievable Inferior Vena Cava Filter
March 15, 2011 3:33 am | by Bio-Medicine.Org | News | CommentsATHENS, Texas, March 15, 2011 /- Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP ("Rex Medical") for exclusive global rights to market and distribute the Option™ Retrievable Inferior Vena Cava Filter, an...
BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm
March 15, 2011 3:33 am | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS, March 15, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ), producer of the FDA cleared Streamway™ System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 ("CFSG1") as its U.S. Investor Relations...
Santarus Stockholders Get Their Share of Disappointing News
March 13, 2011 11:35 pm | by San Diego Business Journal | News | CommentsSantarus Inc. stockholders weren't exactly hopping for joy after the U.S. Food and Drug Administration declined approval Feb. 26 of a product based on a new treatment for hereditary angioedema, or swelling of the face and airways, derived from rabbit's milk.
Untitled
March 10, 2011 5:35 am | by International Osteoporosis Foundation | News | CommentsMore than 4000 already registered! Online registration still open at www.ecceo11-iof.org
Inaugural Herbert A. Fleisch ESCEO-IOF Medal is awarded to Professor Gerard Karsenty
March 8, 2011 10:34 pm | by International Osteoporosis Foundation | News | CommentsThe newly created award recognizes outstanding and groundbreaking achievements in basic bone science. It will be presented on March 23rd at the opening of the European Congress on Osteoporosis & Osteoarthritis in Valencia.
IOF Committee of Scientific Advisors announces six new members
March 8, 2011 12:34 am | by International Osteoporosis Foundation | News | CommentsIncludes two newly elected members from the Middle-East & Africa region
Countdown to Valencia pre-registration deadline - only 3 more days!
March 3, 2011 10:33 pm | by International Osteoporosis Foundation | News | CommentsRegister before March 7 to take advantage of lower registration fees Receive up to 30 CME credits!
Australia to host IOF Regionals - 2nd Asia-Pacific Osteoporosis and Bone Meeting
February 17, 2011 11:34 pm | by International Osteoporosis Foundation | News | CommentsIOF is pleased to announce the 2nd Asia-Pacific Osteoporosis and Bone Meeting, to be held in conjunction with the Australian & New Zealand Bone & Mineral Society (ANZBMS) Annual Scientific Meeting and with the Japanese Bone and Mineral Research Society
Alere Inc. Announces Fourth Quarter 2010 Results
February 17, 2011 2:32 am | by Bio-Medicine.Org | News | CommentsWALTHAM, Mass., Feb. 17, 2011 /- Alere Inc. (NYSE: ALR ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended December 31, 2010. Financial...
Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
February 15, 2011 7:32 am | by Bio-Medicine.Org | News | CommentsIRVINE, Calif., Feb. 15, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON (International Congress of Endovascular Specialists)...
FDA Clears First Patient-Specific Implant System for Total Knee Replacement
February 15, 2011 4:51 am | News | CommentsBurlington, Mass.- February 3, 2011 - ConforMIS has received 510(k) clearance from the U.S. Food and Drug Administration to commercially market its iTotal® CR Knee Replacement System.
PTC Therapeutics and Parent Project Muscular Dystrophy Advance Drug Discovery Program to Improve Heart Function in Duchenne/Becker Muscular Dystrophy Patients
February 1, 2011 10:33 am | by Bio-Medicine.Org | News | CommentsSOUTH PLAINFIELD, N.J. and HACKENSACK, N.J., Feb. 1, 2011 /- PTC Therapeutics, Inc. (PTC) and Parent Project Muscular Dystrophy (PPMD) today announced an expansion of their collaboration to discover new treatments for patients with Duchenne/Becker muscular dystrophy (DBMD). PPMD has...
Ongoing Negotiation on Top Brand Health Device Cooperation
February 1, 2011 10:32 am | by Bio-Medicine.Org | News | CommentsSHENZHEN, China, Feb. 1, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International Trading Co., a rapidly growing international trading company in China, unveiled its currently ongoing business negotiations and possible prospective business partners today, as the...
UBM Studios Virtual Event Connects the UBM Canon Medical Device Media Group with the Medical Device Design Community
February 1, 2011 4:35 am | by Bio-Medicine.Org | News | CommentsCHICAGO, Feb. 1, 2011 /- UBM Canon Medical Device Media Group's MD+DI , MPMN and OrthoTec presented the " Technological Advances in Implantable Devices " virtual event on January 26, 2011 from 11 a.m. – 5 p.m. Eastern. The event is dedicated to cutting-edge trends in the...
CardioGenics to Continue Commercialization of its Magnetic Beads with Merck Chimie SAS
February 1, 2011 4:35 am | by Bio-Medicine.Org | News | CommentsMISSISSAUGA, Ontario, Feb. 1, 2011 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH ) announced today that CardioGenics and Merck Chimie SAS continue the commercialization process of CardioGenics' magnetic beads. Merck recently notified CardioGenics that while it is refining...
CryoLife Announces Release Date and Teleconference Call Details for 2010 Fourth Quarter and Year End Financial Results
February 1, 2011 4:34 am | by Bio-Medicine.Org | News | CommentsATLANTA, Feb. 1, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 fourth quarter and year end financial results will be released on Thursday, February 17, 2011. On that day, the...
CareFusion Names Kieran T. Gallahue Chairman and CEO
February 1, 2011 4:34 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Feb. 1, 2011 /- CareFusion Corporation (NYSE: CFN ), a global, medical technology company, announced today the appointment of Kieran T. Gallahue as chairman and chief executive officer, succeeding David L. Schlotterbeck who previously announced plans to retire later this month....
China SHESAYS Announces Preliminary Unaudited Results for FY 2010; Provides Business Outlook Update for Investors
February 1, 2011 4:34 am | by Bio-Medicine.Org | News | CommentsCHENGDU, China, Feb. 1, 2011 /PRNewswire-Asia-FirstCall/ -- China SHESAYS Medical Cosmetology Inc. (OTC Bulletin Board: CSAY ) ("China SHESAYS" or the "Company"), which operates a network of specialized medical cosmetology hospitals, clinics and skincare centers in Sichuan province,...
